Kourtney Kardashian is getting called out for spreading misinformation about the health risks of blue surgical masks amid the coronavirus pandemic.
Kourtney Kardashian is getting called out for spreading misinformation about the health risks of blue surgical masks amid the coronavirus pandemic.
Somalia ordered the expulsion of Kenya's ambassador after accusing neighbouring Kenya of interfering in the electoral process in Jubbaland, one of Somalia's five semi-autonomous states, the latest dispute between the two countries. "As a result of the Kenyan government's political interferences in the internal affairs of Somalia, the regional President of Jubbaland has reneged on the election agreement that was reached on the 17th September 2020 in Mogadishu," the Somali Foreign Ministry said in a statement on Facebook.
Global investors are betting Chinese stocks will extend their bull run and that mainland corporate earnings in 2021 will be boosted by a world economic recovery and more predictable Sino-U.S. relationship. "China will deliver one of the strongest and fastest macro recoveries in 2021 among major economies globally," Goldman Sachs said in its China outlook report, forecasting a 20% rebound in Chinese corporate profits, and staying overweight Chinese equities. Morgan Stanley also remains overweight China, forecasting "solid" earnings growth amid the backdrop of a strong, broad-based global recovery, and a potentially more predictable trade environment once Joe Biden replaces Donald Trump in the White House.
Vaccine maker Novavax Inc said on Monday it has pushed back the start of a U.S.-based, late-stage trial for its experimental COVID-19 vaccine and now expects it to begin in the coming weeks instead of November. It is the second time that Novavax, which already has a late-stage UK trial underway, has rescheduled the Phase 3 trial after first flagging an October start, hampered by issues in scaling up its manufacturing. Novavax plans to use vaccine material produced at commercial scale for the trial in the United States and Mexico and has been working closely with the U.S. Food and Drug Administration to greenlight the use of the vaccine made at a North Carolina plant.
Some fans had no idea that the two are father and daughter.
Blue Apron Holdings, Inc. (NYSE: APRN) today announced the appointment of Charlean Gmunder as Chief Operating Officer, effective as of November 25, 2020. Gmunder brings more than 30 years of food operations experience to her new role, including deep knowledge in food manufacturing and fulfillment. As Chief Operating Officer, Gmunder is responsible for overseeing Blue Apron’s fulfillment, supply chain, Food Safety and Quality Assurance, physical operations, including logistics, procurement and customer experience. Gmunder reports to President and Chief Executive Officer Linda Findley Kozlowski.
Aphria Inc. ("Aphria", "we" or the "Company") (TSX: APHA) (NASDAQ: APHA), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, announced it has closed the accretive, strategic acquisition (the "Acquisition") of SW Brewing Company, LLC ("SweetWater Brewing Company" or "SweetWater"), one of the largest independent craft brewers in the United States ("U.S.") based on volume. Beginning with the flagship 420 beverage offerings, SweetWater has created an award-winning lineup of year-round, seasonal and specialty beers, a portfolio of brands closely aligned with a cannabis lifestyle.
Infostretch has been recognized as a leader in digital engineering services by the consulting, research and advisory firm, Zinnov, in its annual Zinnov Zones research report into the state of global enterprise engineering research and development (ER&D) services. Zinnov Zones for ER&D Services – 2020 assessed the engineering and R&D-led product and service initiatives of 60 companies globally across eight vertical sectors. The report recognized Infostretch’s ER&D capabilities across five key zones and positioned the company as leader in four of them. These include telemedicine; AI / ML engineering in banking, financial services and insurance (BFSI); AI engineering, and in the category for small and medium ER&D providers.
* Pivotal Phase 3 trial in United Kingdom completes enrollment * Phase 2b efficacy trial in South Africa completes enrollment * U.S./Mexico Phase 3 trial expected to begin in the coming weeksGAITHERSBURG, Md., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today provided an update on its COVID-19 vaccine program. NVX‑CoV2373 is a stable, prefusion protein antigen derived from the genetic sequence of the SARS-CoV-2 coronavirus spike (S) protein and adjuvanted with Novavax’ proprietary Matrix‑M™.“Novavax is in a leading position to significantly contribute to the need for safe and efficacious vaccines that will ultimately end the worldwide COVID-19 pandemic,” said Stanley C. Erck, President and Chief Executive Officer, Novavax. “We continue to make meaningful progress as we work to test, manufacture and ultimately deliver NVX-CoV2373 with unprecedented speed, as well as put partnerships in place that would ensure widespread and equitable access worldwide.”Two of the three planned late-stage efficacy trials for NVX-CoV2373 sponsored by Novavax are fully enrolled, and more than 20,000 participants have been dosed to-date. The primary efficacy endpoints for these trials have been harmonized and reviewed by global regulatory agencies in order to facilitate regulatory approval and ensure that the results are generalizable across global populations. In alignment with Novavax’ commitment to transparency, Phase 3 clinical trial protocols are posted to the company’s website at Novavax.com/resources upon finalization.United Kingdom (U.K.) pivotal Phase 3 trial updateNovavax completed enrollment of 15,000 participants in a pivotal Phase 3 clinical trial being conducted in the U.K. to determine efficacy and safety of NVX-CoV2373. The U.K. Vaccines Taskforce and National Institute for Health Research played pivotal roles in the rapid recruitment and enrollment of volunteers.Interim data in this event-driven trial are expected as soon as early first quarter 2021, although the timing depends on the overall COVID-19 rate in the region. These data are expected to serve as the basis for licensure application in the U.K., European Union and other countries. More than 25 percent of enrollees in the trial are over the age of 65, while a large proportion of volunteers had underlying co-morbid medical conditions generally representative of the population.South Africa Phase 2b trial updateThe Phase 2b trial taking place in South Africa to evaluate safety and provide an early indication of efficacy is now fully enrolled. A total of 4,422 volunteers are taking part in the trial, which includes 245 medically stable, HIV-positive participants.This trial is expected to increase the body of efficacy data of NVX-CoV2373 in racially and geographically diverse populations as well as in older adults. As in the U.K., availability of efficacy data depends on the illness rate in South Africa and may be available as soon as the first quarter 2021. The trial is being conducted in collaboration with Professor Shabir Mahdi and Wits University and is funded in part by the Bill & Melinda Gates Foundation. The Coalition for Epidemic Preparedness Innovations (CEPI) funded the manufacturing of doses of NVX-CoV2373 for this Phase 2b clinical trial.U.S./Mexico pivotal Phase 3 trial updateNovavax expects its pivotal Phase 3 clinical trial in the United States and Mexico to begin in the coming weeks. More than 100 trial sites have been selected with some alternate sites in place, should they be needed.Preliminary blinded data on NVX-CoV2373 in older adults needed to proceed to Phase 3 has previously been positively reviewed by the Food and Drug Administration (FDA). Additional clinical data from the Phase 2 trial conducted in the U.S. and Australia are expected to be unblinded in Q1 and will be targeted for publication.Novavax will use vaccine material produced at commercial scale for this trial. Therefore, the Company has been working closely with the FDA to complete trial-initiation gating activities related to its commercial-scale production at FUJIFILM Diosynth Biotechnologies in Research Triangle Park, North Carolina.Novavax was awarded $1.6 billion in funding from the U.S. government to meet its Operation Warp Speed goals to expedite the delivery of millions of doses of safe, effective vaccines for COVID-19. The award is funding the U.S. and Mexico pivotal Phase 3 trial and manufacturing scale-up. About NVX-CoV2373 NVX-CoV2373 is a protein-based vaccine candidate engineered from the genetic sequence of SARS-CoV-2, the virus that causes COVID-19 disease. NVX-CoV2373 was created using Novavax’ recombinant nanoparticle technology to generate antigen derived from the coronavirus spike (S) protein adjuvanted with Novavax’ patented saponin-based Matrix-M™ to enhance the immune response and stimulate high levels of neutralizing antibodies. NVX-CoV2373 contains purified protein antigen and can neither replicate, nor can it cause COVID-19. In preclinical studies, NVX-CoV2373 induced antibodies that block binding of spike protein to cellular receptors and provided protection from infection and disease. NVX-CoV2373 was generally well-tolerated and elicited robust antibody responses numerically superior to that seen in human convalescent sera in Phase 1/2 clinical testing. NVX-CoV2373 is being evaluated in a Phase 3 trial in the U.K. and two ongoing Phase 2 studies that began in August: a Phase 2b trial in South Africa, and a Phase 1/2 continuation in the U.S. and Australia. Novavax has secured $2 billion in funding for its global coronavirus vaccine program, including up to $399 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI) and more than $1.6 billion from the U.S. Government’s Operation Warp Speed program.About Novavax Novavax, Inc. (Nasdaq: NVAX) is a late-stage biotechnology company that promotes improved health globally through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases. Novavax is undertaking clinical trials for NVX-CoV2373, its vaccine candidate against SARS-CoV-2, the virus that causes COVID-19. NanoFlu™, its quadrivalent influenza nanoparticle vaccine, met all primary objectives in its pivotal Phase 3 clinical trial in older adults. Both vaccine candidates incorporate Novavax’ proprietary saponin-based Matrix-M™ adjuvant to enhance the immune response and stimulate high levels of neutralizing antibodies. Novavax is a leading innovator of recombinant vaccines; its proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles in order to address urgent global health needs.For more information, visit www.novavax.com and connect with us on Twitter and LinkedIn.Novavax Forward Looking Statements Statements herein relating to the future of Novavax and the ongoing development of its vaccine and adjuvant products are forward-looking statements. Novavax cautions that these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include those identified under the heading “Risk Factors” in the Novavax Annual Report on Form 10-K for the year ended December 31, 2019, and Quarterly Report on Form 10-Q for the period ended September 30, 2020, as filed with the Securities and Exchange Commission (SEC). We caution investors not to place considerable reliance on forward-looking statements contained in this press release. You are encouraged to read our filings with the SEC, available at sec.gov, for a discussion of these and other risks and uncertainties. The forward-looking statements in this press release speak only as of the date of this document, and we undertake no obligation to update or revise any of the statements. Our business is subject to substantial risks and uncertainties, including those referenced above. Investors, potential investors, and others should give careful consideration to these risks and uncertainties. CONTACT: Contacts: Investors Erika Trahan firstname.lastname@example.org 240-268-2022 Media Edna Kaplan email@example.com 617-974-8659
FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION(a) Full name of discloser:Investec Wealth & Investment (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Urban&Civic Plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure27th November 2020 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” 2. POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)Class of relevant security: InterestsShort positions Number%Number% (1) Relevant securities owned and/or controlled:12,821,2448.83% (2) Cash-settled derivatives: (3) Stock-settled derivatives (including options) and agreements to purchase/sell: TOTAL:12,821,2448.83% All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).(b) Rights to subscribe for new securities (including directors’ and other employee options)Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSUREWhere there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.The currency of all prices and other monetary amounts should be stated.(a) Purchases and salesClass of relevant securityPurchase/sale Number of securitiesPrice per unit Ordinary Shares Sale 10,500 343p (b) Cash-settled derivative transactionsClass of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit (c) Stock-settled derivative transactions (including options)(i) Writing, selling, purchasing or varyingClass of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit (ii) ExerciseClass of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit (d) Other dealings (including subscribing for new securities)Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable) 4. OTHER INFORMATION(a) Indemnity and other dealing arrangementsDetails of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” N/A (b) Agreements, arrangements or understandings relating to options or derivativesDetails of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none” N/A (c) AttachmentsIs a Supplemental Form 8 (Open Positions) attached?NO Date of disclosure:30th November 2020 Contact name:Phil Beardwell Chartered FCSI Telephone number:020 7597 1356 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at firstname.lastname@example.org. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.
Amesite Inc. (Nasdaq: AMST), an artificial intelligence software company providing online learning ecosystems for business, higher education, and K-12, announced today its Founder & CEO, Dr. Ann Marie Sastry, will present to the investment community at the following virtual events:
Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI), an agriculture products supplier in China, today announced its participation in the Shanghai International Health, Wellness and Fitness Expo (the "Expo"), which was held from November 25 to 27, 2020. The Expo, the largest of its kind in Asia, included edible fungi in its featured products.
Elim verifies and releases significant copper intercepts from select previously unreleased historic drill holes obtained in the Cactus acquisition.
VERO BEACH, Florida, Nov. 30, 2020 (GLOBE NEWSWIRE) -- ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today announced the December 2020 cash dividend for the Company's Common Stock. December 2020 Common Stock Dividend InformationMonth Dividend Holder of Record Date Payment Date December 2020 $0.10 December 15, 2020 December 29, 2020 Certain Tax MattersARMOUR has elected to be taxed as a real estate investment trust (“REIT”) for U.S. Federal income tax purposes. In order to maintain this tax status, ARMOUR is required to timely distribute substantially all of its ordinary REIT taxable income. Dividends paid in excess of current tax earnings and profits for the year will generally not be taxable to common stockholders. Actual dividends are determined at the discretion of the Company’s board of directors, which may consider additional factors including the Company’s results of operations, cash flows, financial condition and capital requirements as well as current market conditions, expected opportunities and other relevant factors.About ARMOUR Residential REIT, Inc.ARMOUR invests exclusively in fixed rate residential, adjustable rate and hybrid adjustable rate residential mortgagebacked securities issued or guaranteed by U.S. Government-sponsored enterprises or guaranteed by the Government National Mortgage Association. ARMOUR is externally managed and advised by ARMOUR Capital Management LP, an investment advisor registered with the Securities and Exchange Commission (“SEC”).Safe HarborThis press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. The Company disclaims any obligation to release publicly any updates or revisions to any forward-looking statement to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.Additional Information and Where to Find ItInvestors, security holders and other interested persons may find additional information regarding the Company at the SEC’s internet site at www.sec.gov, or the Company website at www.armourreit.com, or by directing requests to: ARMOUR Residential REIT, Inc., 3001 Ocean Drive, Suite 201, Vero Beach, Florida 32963, Attention: Investor Relations.Investor Contact: James R. Mountain Chief Financial Officer ARMOUR Residential REIT, Inc. (772) 617-4340
FORT WORTH, Texas, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Contango Oil & Gas Company (NYSE American: MCF) (“Contango” or the “Company”) announced today that it has entered into an asset purchase agreement to acquire assets in the Big Horn, Permian, and Powder River Basins via a bank owned liquidation of assets. HIGHLIGHTS * Acquisition of PDP heavy reserves for $58 million in cash, subject to customary purchase price adjustments, representing more than a 50% discount to producing reserve value(1) * Adds significant volumes of low-decline liquids production requiring minimal maintenance capital * Pro forma for the Mid-Con Energy merger and this acquisition, Contango’s net producing oil annual decline rate to drop to approximately 11% during 2021 * Pro forma(2) for the Mid-Con Energy merger, these assets are expected to increase Contango’s reserve value by approximately 36% * Unlevered payback period on these assets estimated to be 2.7 years at 11/27/20 strip. Long-lived, conventional asset package is expected to retain a majority of its value and production volumes through payout and continue to produce significant cash flow thereafter * Significant potential for cash flow optimization through Contango’s proven ability to cut costs on acquired assets. Large scale assets will also provide future inventory of low-risk capital projects that we are currently evaluatingTRANSACTION DETAILSThe executed purchase and sale agreement provides that Contango will acquire approximately 7.5 Mboe/d of production (as of 8/1/20), approximately 18.3 Mmboe of PDP reserves (unaudited), and ~182,000 net acres (100% HBP) across the package for a total purchase price of $58 million subject to customary purchase price adjustments.Production from the acquired assets is liquids weighted at >55% oil and NGLs, and the acreage is 100% held-by-production. The largest property in the package, the Elk Basin Field (Big Horn Basin), is a conventional asset which has been producing from multiple horizons for over 100 years. This field has produced in excess of 500 million barrels of oil since discovery with historic estimates of the OOIP in excess of 1.2 billion barrels. This field currently produces approximately 2 Mboe/d (87% oil and 100% liquids), having exhibited low single digit decline rates for several decades. The second largest asset in the portfolio, located on the Central Basin Platform and Northwest Shelf areas of the Permian Basin, currently produces 3.8 Mboe/d (40% oil and 59% liquids).The transaction is expected to close December 31, 2020, and the effective date of the transaction will be August 1, 2020.The closing of the transaction is subject to customary conditions, due diligence, confirmation of title, and finalization of documentation; however, closing is not conditioned upon satisfaction of any financing contingency. The Company intends to finance the purchase price with a combination of cash on hand, borrowings under its revolving credit facility and capital markets financing.MANAGEMENT COMMENTARYWilkie S. Colyer, Contango’s Chief Executive Officer, said “We are extremely excited to acquire these oily, low decline assets at such an attractive valuation. This opportunity became actionable as a result of our proprietary pipeline of assets owned by non-natural owners, and our hope is that, as in this case, sellers view us as a solution provider as much as they do a counterparty in looking for a new home for stranded assets. Contango has existing operations in the Big Horn, Permian, and Powder River Basins, and we believe we have the expertise to maximize the value of these mature conventional assets via our technical staff formerly at Mid-Con Energy. This is another step for us in consolidating upstream assets in a difficult environment for the industry as a whole. We will continue to be on the lookout for transactions accretive to our shareholders, defined as ones which increase intrinsic value per share, whether they be cash purchases, M&A, reorganizations, or distressed debt acquisitions in what continues to be a target rich environment for us.”(1) Value of producing reserves as of November 1, 2020, as calculated by MCF using seller provided unaudited reserves information and 8/4/2020 Nymex strip pricing.(2) Pro forma proved reserves of $364.6mm after the Mid-Con merger. These pro forma proved reserves for MCF and MCEP Combined are as of 12/31/2019 using strip pricing as of 8/4/2020 and exclude reserves associated with MCF’s ~37% interest in Exaro. The properties subject to this pending acquisition have an estimated $130.3mm in proved reserves value, as set forth in footnote 1 above, which results in an approximate 36% increase in proved reserves value over pro forma Combined MCF and MCEP. Teleconference CallContango management will hold a conference call to discuss the information described in this press release on Monday, November 30, 2020 at 3:30 pm Central Standard Time. A brief presentation related to certain items to be discussed on the call will be posted to the Company’s website at ir.contango.com prior to the call. Those interested in participating in the conference call may do so by clicking here to join and entering your information to be connected. The link becomes active 15 minutes prior to the scheduled start time, and the conference will call you. If you are not at a computer, you can join by dialing 1-800-309-1256, (International 1-323-347-3622) and entering participation code 538266. A replay of the call will be available Monday, November 30, 2020 at 6:30 pm CST through Monday, December 21, 2020 at 7:00 pm CST by clicking here.About Contango Oil & Gas CompanyContango Oil & Gas Company is a Houston, Texas based, independent oil and natural gas company whose business is to maximize production and cash flow from its offshore properties in the shallow waters of the Gulf of Mexico and onshore properties in Texas, Oklahoma, Louisiana and Wyoming and, when determined appropriate, to use that cash flow to explore, develop, and increase production from its existing properties, to acquire additional PDP-heavy crude oil and natural gas properties or to pay down debt. Additional information is available on the Company's website at http://contango.com. Information on our website is not part of this release.ADDITIONAL INFORMATION AND WHERE TO FIND ITThis communication may be deemed to be solicitation material in respect of the proposed merger (the “Proposed Merger”). The Proposed Merger will be submitted to Contango’s shareholders and Mid-Con’s unitholders for their consideration. Contango and Mid-Con intend to file a preliminary consent statement/proxy statement/prospectus (the “Consent Statement/Proxy Statement/Prospectus”) with the Securities and Exchange Commission (the “SEC”) in connection with the Partnership Unitholder Approval and the Contango Shareholder Approval (each as defined in the Merger Agreement) in connection with the Proposed Merger. Contango intends to file a registration statement on Form S-4 (the “Form S-4”) with the SEC, in which the Consent Statement/Proxy Statement/Prospectus will be included as a prospectus. Contango and Mid-Con also intend to file other relevant documents with the SEC regarding the Proposed Merger. After the Form S-4 is declared effective by the SEC, the definitive Consent Statement/Proxy Statement/Prospectus will be mailed to Contango’s shareholders and Mid-Con’s unitholders. BEFORE MAKING ANY VOTING OR INVESTMENT DECISION WITH RESPECT TO THE PROPOSED MERGER, INVESTORS AND SHAREHOLDERS OF CONTANGO AND INVESTORS AND UNITHOLDERS OF MID-CON ARE URGED TO READ THE DEFINITIVE CONSENT STATEMENT/PROXY STATEMENT/PROSPECTUS REGARDING THE PROPOSED MERGER (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND OTHER RELEVANT MATERIALS CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED MERGER.The Consent Statement/Proxy Statement/Prospectus, any amendments or supplements thereto and other relevant materials, and any other documents filed by Contango or Mid-Con with the SEC, may be obtained once such documents are filed with the SEC free of charge at the SEC’s website at www.sec.gov or free of charge from Contango at www.contango.com or by directing a request to Contango’s Investor Relations Department at email@example.com or free of charge from Mid-Con at www.mceplp.com or by directing a request to Mid-Con’s Investor Relations Department at MSA.OwnerRelations@Contango.com.NO OFFER OR SOLICITATIONThis communication does not constitute an offer to sell or the solicitation of an offer to buy any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.PARTICIPANTS IN THE SOLICITATIONContango, Mid-Con and certain of their respective executive officers, directors, other members of management and employees may, under the rules of the SEC, be deemed to be “participants” in the solicitation of proxies in connection with the Mid-Con Acquisition. Information regarding Contango’s directors and executive officers is available in its Proxy Statement on Schedule 14A for its 2020 Annual Meeting of Shareholders, filed with the SEC on April 28, 2020 and in its Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on March 20, 2020. Information regarding Mid-Con’s directors and executive officers is available in its Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on March 12, 2020 and its Current Reports on Form 8-K, filed with the SEC on June 10, 2020 and August 6, 2020. These documents may be obtained free of charge from the sources indicated above. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the Form S-4, the Consent Statement/Proxy Statement/Prospectus and other relevant materials relating to the Mid-Con Acquisition to be filed with the SEC when they become available. Shareholders, unitholders, potential investors and other readers should read the Consent Statement/Proxy Statement/Prospectus carefully when it becomes available before making any voting or investment decisions.Forward-Looking Statements and Cautionary StatementsThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on Contango’s current expectations and include statements regarding our estimates of future production and other guidance (including information regarding production, asset potential and cost reductions), the Company’s pending acquisition of the oil and gas properties and the timing and benefits therefrom, the Company’s pending acquisition of Mid-Con, the pro forma profile of the Company after giving effect to both acquisitions, the Company’s drilling program and capital expenditures, our liquidity and access to capital, expected reduction in overall drilling costs, the potential impact of the COVID-19 pandemic including reduced demand for oil and natural gas, the low and volatile commodity price environment, the impact of our derivative instruments, the accuracy and use of technical information and staff, the accuracy of our projections of future production, future results of operations, ability to identify and complete acquisitions and other strategic opportunities, ability to realize expected benefits of acquisitions the quality and nature of the asset base, our outlook in the current industry downturn, the assumptions upon which estimates are based (including those regarding assets we do not yet own), beliefs, plans, objectives, assumptions, strategies or statements about future events or performance. Words and phrases used to identify our forward-looking statements include terms such as “guidance”, “expects”, “projects”, “anticipates”, “believes”, “plans”, “estimates”, “potential”, “possible”, “probable”, “intends”, “forecasts”, “view”, “efforts”, “goal”, “positions” or words and phrases stating that certain actions, events or results “may”, “will”, “should”, or “could” be taken, occur or be achieved. Statements concerning oil and gas reserves also may be deemed to be forward-looking statements in that they reflect estimates based on certain assumptions that the resources involved can be economically exploited. Forward-looking statements are based on current expectations, estimates and projections that involve a number of risks and uncertainties, which could cause actual results to differ materially from those reflected in the statements. These risks include, but are not limited to: the risks of the oil and gas industry (for example, operational risks in exploring for, developing and producing crude oil and natural gas; risks and uncertainties involving geology of oil and gas deposits; the uncertainty of reserve estimates; the uncertainty of estimates and projections relating to future production, costs and expenses; potential delays or changes in plans with respect to exploration or development projects or capital expenditures; health, safety and environmental risks and risks related to weather such as hurricanes and other natural disasters); risks relating to the Company’s pending acquisitions of oil and gas properties and of Mid-Con, including the risk that the acquisitions will not be completed on the timeline or terms currently contemplated, that the businesses will not be integrated successfully, that the cost savings, synergies and growth from the acquisitions may not be fully realized or may take longer to realize than expected, and that management attention will be diverted to transaction-related issues; potential liability resulting from litigation related to the Mid-Con acquisition; the risk that transaction costs for the acquisitions may be higher than anticipated; the effect of our pending acquisitions (or announcement thereof) or financing thereof on our stock price or Mid-Con’s unit price; uncertainties as to the availability and cost of financing; our relationships with lenders; our ability to comply with financial covenants in our debt instruments, repay indebtedness and access new sources of indebtedness and/or provide additional liquidity for future capital expenditures; any reduction in our borrowing base and our ability to avoid or repay excess borrowings as a result of such reduction; our ability to execute on our strategy, including execution of acquisitions, any changes in our strategy or our fee for service offering; fluctuations in or sustained low commodity prices; availability and effect of storage of production; expected benefits of and risks associated with derivative positions; our ability to realize cost savings; our ability to execute on and realize expected value from acquisitions and to complete strategic dispositions of assets and realize the benefits of such dispositions; the need to take impairments on properties due to lower commodity prices; the limited trading volume of our common stock and general trading market volatility; outbreaks and pandemics, even outside our areas of operation, including COVID-19 and the resulting economic slowdown, governmental actions, stay-at-home orders, and other interruptions to our operations; the ability of our management team to execute its plans or to meet its goals; shortages of drilling equipment, oil field personnel and services; unavailability of gathering systems, pipelines and processing facilities; the possibility that government policies may change or governmental approvals may be delayed or withheld; and the other factors discussed in our reports filed or furnished with the SEC, including under the “Risk Factors” heading in our annual report on Form 10-K for the year ended December 31, 2019 and our quarterly reports on Form 10-Q filed with the SEC. Additional information on these and other factors, many of which may be unknown or unpredictable at this time, which could affect Contango’s operations or financial results are included in Contango’s reports on file with the SEC. Investors are cautioned that any forward-looking statements are not guarantees of future performance and actual results or developments may differ materially from the projections in the forward-looking statements. Forward-looking statements speak only as of the date they were made and are based on the estimates and opinions of management at the time the statements are made. Contango does not assume any obligation to update forward-looking statements should circumstances or management’s estimates or opinions change, except as required by law. Production rates are subject to decline over time and should not be regarded as reflective of sustained production levels. Pro forma information represents expectations based on current information and expected benefits of any transaction are not necessarily indicative of future or long-term results. Original oil in place, producing reserves, past production performance and PV-10 are not necessarily representative of future cash flows and production, which may be materially less. This release shall not constitute an offer to sell, or a solicitation of an offer to buy, any securities.Contact:Contango Oil & Gas Company Farley Dakan – 817-502-6254 President
Electric Motors Market is poised to experience spend growth of more than USD 45 billion between 2020-2024 at a CAGR of over 6.00%.
Air fryer deals for Cyber Monday, featuring Cuisinart, Philips, Ninja, and Instant air fryer toaster oven discountsCyber Monday air fryer deals have landed. Find the top offers on Philips, Cuisinart, Instant, Ninja, and more toaster ovens. Access the latest deals using the links below.Best Air Fryer Deals: * Save up to 60% on air fryers from top brands like Cuisinart, Ninja, Farberware, NuWave & Philips at Walmart \- check the latest deals on a wide range of top-rated air fryers and air fryer ovens * Save up to 52% on Ninja Foodi air fry ovens & multi-use home food cookers at Walmart \- save on the latest Ninja Foodi multi-use air fryers, convection ovens & pressure cookers * Save up to 55% on a wide range of air fryers at Amazon \- check live prices on top-selling brands including Farberware, Ninja, Philips, Cuisinart & more top-rated kitchen brands * Save up to 55% off on air fryers from top-tier brands like Ninja, Philips, Cuisinart, and more at Target - click the link to see the latest discounts on a wide range of air fryers and air fryer ovens * Save up to $75 on Ninja air fryers at NinjaKitchen.com \- find the latest deals on 2-basket Ninja air fryer ovens at Ninja’s online store * Save up to 50% on Instant Pot multi-use pressure cookers & air fryers at Walmart \- click the link for the latest prices on 6 quart, 3 quart, Ultra & DUO Instant Pot models * Save up to $120 on Ninja air fryers at Walmart * Save up to $60 on KitchenAid countertop ovens with air fry at KitchenAid.com * Save up to 20% on Breville Smart Oven Air Fryers & Smart Oven countertop & convection ovens at Breville.com * Save up to $105 on Philips Premium, Digital & TurboStar air fryers at Amazon \- check live prices on the latest Philips air fryers * Save up to 55% on Cuisinart air fryers & air fryer ovens at Amazon \- click the link for the latest prices on best-selling Cuisinart air fryers * Save up to 56% on top-rated air fryer ovens from Ninja, Instant, Black + Decker, and more top brands at Walmart \- check the latest deals on a wide range of stainless steel air fryer ovens * Save up to 31% off on air fryer ovens from top brands like Instant Pot, Cuisinart, and more at Target - click the link for the latest discounts on a wide range of top-rated air fryer ovens * Save up to 62% off on air fryer ovens & toaster ovens from Cuisinart, Breville, and Ninja at Amazon - see the latest discounts on top-rated air fryer convection ovens for oil-free and low-fat cooking * Save up to $75 on Ninja air fryers at NinjaKitchen.com \- find the latest savings on Ninja air fryer ovens at Ninja’s online store Interested in more deals? Check out Walmart’s Cyber Monday sale and Amazon’s Cyber Monday deals for thousands more live discounts. Deal Tomato earns commissions from purchases made using the links provided.About Deal Tomato: Deal Tomato reports on popular sales events. As an Amazon Associate and affiliate Deal Tomato earns from qualifying purchases.Contact: Andy Mathews (firstname.lastname@example.org)
Cyber Monday robot vacuum deals are underway, explore all the top Cyber Monday iRobot Roomba, Shark ION & more sales below Cyber Monday robot vacuum deals have arrived. Compare the top savings on Roborock S6 MAX Pure, Roomba e-series robovacs & Shark IQ vacuums. Access the best deals in the list below.Best Robot Vacuum Deals: * Save up to 69% on robot vacuums by Shark IQ, iRobot Roomba, Samsung POWERbot, Neato, ILIFE & eufy and more at Walmart \- check the latest deals on a wide range of robot vacuums with Wi-Fi connectivity * Save up to $380 on select Roomba robot vacuums & bundle deals at iRobot.com \- save on the Roomba i3, 960, e5, 675 & more top-rated models and Braava robot mops * Save up to 71% off on robot vacuum cleaners at Target \- check the latest deals on robot vacuum cleaners from bObsweep, Ecovacs, iRobot & more * Save up to 50% on a wide range of robot vacuums at Amazon \- check live deals available on top rated robot vacuums from iRobot Roomba, Shark ION, Neato, eufy, Roborock, Samsung POWERbot & ILIFE * Save up to 46% on a wide range of Roomba robot vacuum bundles & deals at Walmart \- check deals available on the Roomba 980, 960, 690, Braava jet M6 and more new and refurbished models * Save up to $200 on Roomba robot vacuums & robot mops at Target \- save on iRobot smart cleaning products including the Roomba 675, e5, Braava Jet 230 robot mop & more * Save up to $75 on Shark robot vacuums at Sharkclean.com \- check the latest savings on Shark IQ, ION and VACMOP PRO models, featuring Wi-Fi connectivity and home mapping features * Save up to 77% on the Shark IQ robot vacuum and other Shark robot vacuums at Walmart \- click the link to see the latest deals for the Shark IQ plus discounts on compatible replacement kits and accessories * Save up to 50% on Shark robot vacuums at Target \- check the latest deals on Shark’s top-rated robot vacuum models, including the IQ Self-Empty Robot Vacuum and IQ R100 Robot Vacuum * Save up to $300 on a wide range of Ecovacs Deebot robot vacuums at Ecovacs.com \- check the latest savings on the Deebot Ozmo 920, U2 Pro, T8, and more models * Save up to 53% on a wide range of Neato robot vacuums at Walmart \- click the link for live prices on the Neato Botvac D7, D5, and D6 WiFi-connected robot vacuum models * Save up to 52% off on eufy robot vacuum cleaners and replacement parts at Walmart \- check live prices on the BoostIQ RoboVac 11S (Slim), BoostIQ RoboVac 15C MAX, and more models from eufy by Anker * Save up to $240 on Roborock robot vacuum cleaners at Amazon \- check the latest prices on top-rated Roborock S6, S5 & S4 robot vacuums * Save up to 42% on Neato Botvac robot vacuums at Amazon \- check live prices on best-selling Neato D4, D6 & D7 connected robotic vacuum cleaners with LaserSmart technology, zone cleaning & multi-floor mapping * Save up to 40% on eufy BoostIQ Robovac cleaners at Amazon \- save on top-rated robot vacuums with 1300Pa to 2000Pa suction power and triple filter systems * Save up to 50% on Samsung POWERbot robot vacuums at Amazon \- check live prices on robotic vacuums with self-cleaning brushes, onboard cameras, intelligent power control and recharge & resume featuresSearching for more deals? Click here to check out the entire range of deals at Walmart’s Cyber Monday sale and click here to shop Amazon’s latest Cyber Monday deals. Retail Fuse earns commissions from purchases made using the links provided.About Retail Fuse: Retail Fuse reports the latest retail news. As an Amazon Associate and affiliate Retail Fuse earns from qualifying purchases.Contact: Andy Mathews (email@example.com)
The Lion Electric Company, a leading designer, manufacturer and distributor of all-electric medium and heavy-duty urban vehicles, announced today it intends to combine with Northern Genesis Acquisition Corp. (NYSE: NGA), a publicly traded special purpose acquisition company focused on a commitment to sustainability and strong alignment with environmental, social and governance principles. Upon closing of the transaction, a wholly-owned subsidiary of Lion will merge with and into Northern Genesis, and Lion is expected to be listed on the New York Stock Exchange (NYSE) under the new ticker symbol "LEV".
Wi-LAN Inc. ("WiLAN"), a Quarterhill Inc. ("Quarterhill") company (TSX: QTRH) (OTCQX: QTRHF), today announced that an unnamed handset manufacturer, ranked in the top 20 in sales in the USA, has signed a multi-year license to WiLAN's wireless LTE patent portfolio. The license grants global rights covering wireless LTE handsets sold by the manufacturer. All other terms of the license agreement are confidential.
Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, announces that Mr. Juan Carlos Echeverry has been appointed to the Board of Directors of the Company, effective immediately. Mr. Echeverry brings extensive corporate, academic and macroeconomic experience, serving as Colombia's Minister of Finance from 2010 to 2012 and as the CEO and President of Ecopetrol from 2015 to 2017.